Bayer Sells $3.4 Billion Stake in Contraceptives Arm to Apollo
AI Summary
Bayer AG has sold a minority stake valued at $3.4 billion in its contraceptives business to Apollo Global Management. The transaction proceeds will aid Bayer in strengthening its capital structure.
Bayer AG sold a minority stake in its contraceptives business to Apollo Global Management Inc. for €3 billion ($3.4 billion) and will use the funds raised to improve its capital structure.